| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Radiology, Vol 200, 243-247, Copyright © 1996 by Radiological Society of North America
ARTICLES |
F Dehdashti, BA Siegel, LK Griffeth, MJ Fusselman, DD Trask, AH McGuire and DJ McGuire
Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, St. Louis, MO, USA.
PURPOSE: To assess the ability of positron emission tomography (PET) with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG) to allow differentiation of benign from malignant intraosseous lesions. MATERIALS AND METHODS: Twenty patients with strictly intraosseous lesions (five benign and 15 malignant [three primary and 12 metastatic]) were studied with FDG PET. The final diagnosis was confirmed with histopathologic examination in all patients. The uptake of FDG within each lesion was evaluated qualitatively as well as semiquantitatively by determination of the standardized uptake value (SUV). RESULTS: SUV assessment of FDG accumulation within osseous lesions was superior to subjective visual analysis for discriminating benign from malignant lesions. With use of a 2.0 cutoff value for SUV, 14 of 15 malignant lesions were categorized correctly versus 12 of 15 correctly categorized by means of subjective image evaluation; four of five benign lesions were categorized correctly with both techniques. CONCLUSION: FDG PET can aid in differentiating benign from malignant strictly intraosseous lesions.
This article has been cited by other articles:
|
|
 |
|
  D. S. Hawkins, S. M. Schuetze, J. E. Butrynski, J. G. Rajendran, C. B. Vernon, E. U. Conrad III, and J. F. Eary [18F]Fluorodeoxyglucose Positron Emission Tomography Predicts Outcome for Ewing Sarcoma Family of Tumors J. Clin. Oncol., December 1, 2005; 23(34): 8828 - 8834. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Y.-I. Lee, J. Yu, S.-S. Chang, R. Fawwaz, and M. V. Parisien Diagnostic Value and Limitations of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography for Cartilaginous Tumors of Bone J. Bone Joint Surg. Am., December 1, 2004; 86(12): 2677 - 2685. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Boellaard, N. C. Krak, O. S. Hoekstra, and A. A. Lammertsma Effects of Noise, Image Resolution, and ROI Definition on the Accuracy of Standard Uptake Values: A Simulation Study J. Nucl. Med., September 1, 2004; 45(9): 1519 - 1527. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hamaoka, J. E. Madewell, D. A. Podoloff, G. N. Hortobagyi, and N. T. Ueno Bone Imaging in Metastatic Breast Cancer J. Clin. Oncol., July 15, 2004; 22(14): 2942 - 2953. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Murphey, E. A. Walker, A. J. Wilson, M. J. Kransdorf, H. T. Temple, and F. H. Gannon From the Archives of the AFIP: Imaging of Primary Chondrosarcoma: Radiologic-Pathologic Correlation RadioGraphics, September 1, 2003; 23(5): 1245 - 1278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Brenner, K. H. Bohuslavizki, and J. F. Eary PET Imaging of Osteosarcoma J. Nucl. Med., June 1, 2003; 44(6): 930 - 942. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Bredella, G. R. Caputo, and L. S. Steinbach Value of FDG Positron Emission Tomography in Conjunction with MR Imaging for Evaluating Therapy Response in Patients with Musculoskeletal Sarcomas Am. J. Roentgenol., November 1, 2002; 179(5): 1145 - 1150. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Dimitrakopoulou-Strauss, L. G. Strauss, T. Heichel, H. Wu, C. Burger, L. Bernd, and V. Ewerbeck The Role of Quantitative 18F-FDG PET Studies for the Differentiation of Malignant and Benign Bone Lesions J. Nucl. Med., April 1, 2002; 43(4): 510 - 518. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Aoki, H. Watanabe, T. Shinozaki, K. Takagishi, H. Ishijima, N. Oya, N. Sato, T. Inoue, and K. Endo FDG PET of Primary Benign and Malignant Bone Tumors: Standardized Uptake Value in 52 Lesions Radiology, June 1, 2001; 219(3): 774 - 777. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Schulte, D. Brecht-Krauss, B. Heymer, A. Guhlmann, E. Hartwig, M. R. Sarkar, C. G. Diederichs, A. V. Baer, J. Kotzerke, and S. N. Reske Grading of Tumors and Tumorlike Lesions of Bone: Evaluation by FDG PET J. Nucl. Med., October 1, 2000; 41(10): 1695 - 1701. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Messa, C. Landoni, C. Pozzato, and F. Fazio Is There a Role for FDG PET in the Diagnosis of Musculoskeletal Neoplasms? J. Nucl. Med., October 1, 2000; 41(10): 1702 - 1702. [Full Text] [PDF]
|
|
|
|
|
|
F. Feldman Musculoskeletal Radiology: Then and Now Radiology, August 1, 2000; 216(2): 309 - 316. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. L. Jager, B. E. C. Plaat, E. G. E. de Vries, W. M. Molenaar, W. Vaalburg, D. A. Piers, and H. J. Hoekstra Imaging of Soft-Tissue Tumors Using L-3-[Iodine-123]Iodo-{{alpha}}-methyl-tyrosine Single Photon Emission Computed Tomography: Comparison with Proliferative and Mitotic Activity, Cellularity, and Vascularity Clin. Cancer Res., June 1, 2000; 6(6): 2252 - 2259. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. H. Bilsky, E. Lis, J. Raizer, H. Lee, and P. Boland The Diagnosis and Treatment of Metastatic Spinal Tumor Oncologist, December 1, 1999; 4(6): 459 - 469. [Abstract] [Full Text]
|
|
|
|
 |
|
 W. Weder, R. A. Schmid, H. Bruchhaus, S. Hillinger, G. K. von Schulthess, and H. C. Steinert Detection of extrathoracic metastases by positron emission tomography in lung cancer Ann. Thorac. Surg., September 1, 1998; 66(3): 886 - 893. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |
